Adult Arm of DZL All Age Asthma Cohort (ALLIANCE)

Sponsor
LungenClinic Grosshansdorf (Other)
Overall Status
Recruiting
CT.gov ID
NCT02419274
Collaborator
German Center for Lung Research (Other), Research Center Borstel (Other)
350
2
105
175
1.7

Study Details

Study Description

Brief Summary

Deep Phenotyping of adult asthma patients:
  • severity from mild to severe

  • both atopic and non-atopic

  • both childhood and adult onset

  • both smokers and non-smokers

  • corresponding pediatric cohort (Pediatric Arm of DZL All Age Asthma Cohort) with equivalent SOPs regarding collection of biomaterial and clinical data incl. lung function, further processing of biomaterial and further analyses

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The clinical heterogeneity of asthma patients has been increasingly recognised within the last years. Recent studies and articles highlighted the idea of asthma not beeing a single disease but rather a unifying term for multiple phenotypes. Phenotype in this sense is defined as the combination of observable properties of an organism, that are produced by the interactions of a genotype and the environment. In contrast, endotype describes a specific underlying pathophysiological pathway. Linking asthma phenotypes and endotypes in a system biological approach is an important research goal in order to develop targeted therapy, especially for severe asthma.

    The advantage the investigators' cohort provides is the collaboration with an equivalent pediatric cohort. In this setting questions regarding disease onset, exacerbation and chronicity can be posed and worked with in a comprehensive manner.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    350 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The All Age Asthma Cohort (ALLIANCE) of the German Center for Lung Research (DZL), Adult Arm
    Study Start Date :
    Mar 1, 2014
    Anticipated Primary Completion Date :
    Oct 1, 2022
    Anticipated Study Completion Date :
    Dec 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Defining clinical asthma phenotypes by combining clinical, lung function and biomaterial data [2 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 99 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Proven Diagnosis according to current GINA Guideline (2014)

    • Ability to read and understand German

    • Ability to understand and agree to informed consent

    Exclusion Criteria:
    • History of respiratory tract infection within the last 4 weeks before inclusion

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Research Center Borstel Borstel Germany 23845
    2 LungenClinic Grosshansdorf Grosshansdorf Germany 22927

    Sponsors and Collaborators

    • LungenClinic Grosshansdorf
    • German Center for Lung Research
    • Research Center Borstel

    Investigators

    • Principal Investigator: Klaus F Rabe, MD PhD, LungenClinic Grosshansdorf, Grosshansdorf, Germany
    • Principal Investigator: Susanne Krauss-Etschmann, PhD, Research Center Borstel, Borstel, Germany

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    LungenClinic Grosshansdorf
    ClinicalTrials.gov Identifier:
    NCT02419274
    Other Study ID Numbers:
    • DZL-GHD-ERA
    First Posted:
    Apr 17, 2015
    Last Update Posted:
    Mar 1, 2021
    Last Verified:
    Feb 1, 2021
    Keywords provided by LungenClinic Grosshansdorf
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 1, 2021